JOpen, Martian Sales, and Pur Botanicals Ask a Maryland Federal Judge to Dismiss Baltimore's Consumer Protection Ordinance Suit Over the Marketing of O.P.M.S. Kratom Products and ROXY 7-OH Tablets, Arguing the City Is 'Trying to Step Into Enforcement Shoes That Are Meant to Be Filled by State Actors,' Law360 Reports, After the Case Was Removed From Baltimore City Circuit Court on September 1
Three kratom sellers and distributors sued by the City of Baltimore have asked the U.S. District Court for the District of Maryland to dismiss the case, arguing the city is 'trying to step into enforcement shoes that are meant to be filled by state actors,' Law360's Mike Curley reported on October 8, 2026. The city's July 27 complaint, filed in Baltimore City Circuit Court under the city's Consumer Protection Ordinance and removed to federal court on September 1 as Mayor and City Council of Baltimore v. JOpen, LLC, No. 1:26-cv-03463, names JOpen LLC (doing business as A1 Wholesale, Party Nuts, and other names), Martian Sales Inc., and Pur Botanicals LLC, and alleges they marketed O.P.M.S.-branded kratom products and ROXY-branded 7-hydroxymitragynine (7-OH) tablets as safe or therapeutic while failing to disclose that the active ingredients are addictive and act like opioids. The complaint seeks maximum per-violation penalties under the ordinance and injunctions requiring addiction disclosures and corrective advertising, expressly disclaims any federal claim, and Law360's report does not say whether the city has moved to remand the case to state court.
Three kratom sellers and distributors sued by the City of Baltimore have asked a Maryland federal judge to throw out the case, arguing the city "is trying to step into enforcement shoes that are meant to be filled by state actors," Law360's Mike Curley reported on October 8, 2026. The city's suit, which KNT covered when the Baltimore Sun first reported it in late July, alleges the companies misled consumers about the addictive nature of kratom. The defendants are represented by Kilpatrick Townsend and the Law Offices of Thomas J. Thomas, according to Law360, whose report sits behind a paywall and does not identify the assigned judge.
The case is a marketing-deception action rather than an injury suit, and the products it describes span both categories that have divided this year's regulatory debate. The complaint targets O.P.M.S.-branded kratom products, which it describes as capsules, loose powder, and liquid extracts, and it separately quotes marketing for ROXY-branded 7-hydroxymitragynine (7-OH) tablets in 16 mg, 20 mg, and 60 mg strengths, according to the complaint posted by Courthouse News Service. Tablets at those strengths are concentrated 7-OH preparations, distinct from the trace 7-OH in natural leaf, and the complaint's addiction and safety allegations are directed at both product types without drawing that distinction itself.
Who the city sued, and under what law
The complaint, dated July 27, 2026 and signed by Baltimore City Solicitor Ebony M. Thompson with outside counsel Gordon, Wolf & Carney, names JOpen LLC, which it says does business as A1 Wholesale, Evolutionary Organics, Innovo Activas, American Kratom-D, and Party Nuts; Martian Sales Inc.; Pur Botanicals LLC, doing business as Choice Organics; and unnamed John Doe entities. The city alleges the defendants "share principals and membership" and operate as "a web of shell companies and alter egos" that collectively design, label, package, and sell the products, per the complaint. Through July 1, 2026, the complaint says, the products were widely sold in Baltimore at gas stations, convenience stores, corner stores, and smoke and vape shops, and online through the Party Nuts site.
The sole legal basis is the city's Consumer Protection Ordinance, Baltimore City Code Article 2, Section 4. The city alleges two kinds of violations: falsely stating or implying in labeling and marketing that the products are safe or offer therapeutic benefits, and failing to disclose that the active ingredients "are highly addictive substances similar to opioids." Each misleading inducement and each sale is pleaded as a separate violation carrying its own penalty under Section 4-3(B). The requested relief includes the maximum statutory penalties, injunctions requiring addiction disclosures on labels and advertising, an order to stop safety and therapeutic claims, and court-ordered corrective advertising campaigns, according to the complaint's prayer for relief.
The removal, and the argument against the city
The complaint goes out of its way to stay in state court. "The City brings this action exclusively under the City's Ordinance. No federal claims are being asserted," paragraph 16 states, adding that any claim that could be read as federal "is expressly and undeniably disavowed and disclaimed." The defendants removed it anyway. The federal docket shows a notice of removal from the Circuit Court for Baltimore City filed September 1, 2026, opening the case as No. 1:26-cv-03463 in the District of Maryland. Neither the docket listing KNT reviewed nor Law360's report indicates whether the city has moved to remand.
The dismissal argument, as Law360 summarized it, is about who may enforce: the defendants contend that policing kratom marketing is a job reserved for state actors and that a municipality overreached by bringing the case. The report does not describe the statutory or preemption basis for that position, and KNT has not reviewed the motion itself. Baltimore's complaint anticipates a related objection by pointing to the ordinance's own penalty and injunction provisions, Sections 4-3 and 4-5(d), as the source of the city's authority.
A second motion-to-dismiss ruling in the same arc
The Baltimore motion arrives the week after a different addiction-disclosure theory survived the pleading stage. U.S. District Judge Laura T. Swain in Manhattan denied Mitra-9 Brands' motion to dismiss a proposed consumer class action, finding the complaint adequately alleged the company knew its products were addictive and failed to warn, as KNT reported on October 7. That case was brought by a private plaintiff under consumer-protection law; Baltimore's is brought by a city under its own ordinance, and the defendants' challenge goes to the city's standing to enforce rather than to the sufficiency of the addiction allegations. Law360's report gives no briefing schedule or hearing date.
Sources
-
Kratom Cos. Say Baltimore Overreached With Marketing Suit
Law360
Three kratom sellers and distributors are asking a Maryland federal court to throw out a suit from the city of Baltimore alleging they misled consumers about the addictive nature of kratom, arguing the city is trying to step into enforcement shoes that are meant to be filled by state actors. The defendants are represented by Kilpatrick Townsend and the Law Offices of Thomas J. Thomas.
-
Complaint With Jury Demand, Mayor and City Council of Baltimore v. JOpen, LLC, et al.
Circuit Court for Baltimore City (via Courthouse News Service)
Plaintiff Mayor and City Council of Baltimore brings this civil action against Defendants JOpen, LLC (d/b/a A1 Wholesale, Evolutionary Organics, Innovo Activas, American Kratom-D, and Party Nuts), Martian Sales, Inc., Pur Botanicals LLC (d/b/a Choice Organics), John Doe Corporations 1-10, and Other John Doe Entities 1-10 seeking civil penalties and injunctive relief to remedy Defendants' violations of the City's Consumer Protection Ordinance, Baltimore City Code, Art. 2, § 4, in connection with Defendants' unlawful, unfair, and deceptive trade practices in advertising, marketing, and selling highly addictive, dangerous kratom products, including O.P.M.S.-branded products. The City brings this action exclusively under the City's Ordinance. No federal claims are being asserted.
-
Mayor and City Council of Baltimore v. Jopen, LLC, No. 1:26-cv-03463 (D. Md.)
CourtListener
Docket entry 1, September 1, 2026: Notice of Removal from Circuit Court for Baltimore City, Maryland.